South Korea’s Prostate Medication Market Set to Double Amid Aging Population
The market for benign prostatic hyperplasia (BPH) medications is projected to reach 200 billion won by 2026. (Image courtesy of Pixabay/CCL) SEOUL, Aug. 11 (Korea Bizwire) – As South Korea grapples with an aging population, the market for benign …